The U.S. Food and Drug Administration has approved ZYCUBO (copper histidinate) for treating Menkes disease in pediatric patients, making it ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE